Mounjaro and suicidal thoughts: separating concern from evidence

You've seen a headline linking GLP-1 medicines to suicidal thoughts — here's what prompted it

In mid-2023 the European Medicines Agency began a formal review of GLP-1 receptor agonists after reports were submitted to pharmacovigilance databases in Iceland. The concern was whether semaglutide and liraglutide might be associated with suicidal ideation or self-harm. The MHRA conducted its own parallel assessment in the UK.

The review concluded in early 2024. Both agencies found no confirmed causal link. The EMA's committee determined the available data did not support a change to the product labelling for these medicines. The MHRA reached a similar conclusion. Tirzepatide (the active ingredient in Mounjaro) was examined in that same context as a dual GIP/GLP-1 receptor agonist, and no specific signal emerged for it either.

That said, regulators were clear: the evidence base continues to grow, spontaneous reports remain possible, and anyone who develops mood changes, low spirits or thoughts of self-harm while on any GLP-1 medicine should tell their prescriber straight away. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk is specifically how those reports reach the regulator, it matters that patients and clinicians use it.

The broader picture also matters here. Obesity itself is associated with higher rates of depression and psychological distress. Disentangling a medicine's effect from the effect of the condition it treats (and from life circumstances) is genuinely hard. That complexity is part of why the regulatory review found the picture inconclusive rather than clear-cut either way.

What Mounjaro's prescribing information actually says about mental health

The Mounjaro Summary of Product Characteristics (the clinical document that governs how prescribers use this medicine) does not list suicidal ideation, depression or suicidal thoughts as known or expected adverse effects. The established side-effect profile is dominated by gastrointestinal symptoms: nausea, changes in bowel habit, reflux and fatigue, particularly in the early weeks of treatment or after a dose increase, and if you've noticed a persistent throat irritation you can read about whether a Mounjaro cough fits this pattern. The NHS's patient-level guidance on tirzepatide reflects the same picture.

That doesn't mean mood is irrelevant. Rapid weight loss, changes in appetite and the psychological experience of a different relationship with food can all affect how someone feels. Some people report feeling flat or low in the early weeks; others describe improved mood as their health improves. Neither is universal.

If you have a history of depression, anxiety, bipolar disorder or any previous episode of suicidal thinking, this is something a prescriber needs to know about before starting treatment. It doesn't automatically rule Mounjaro out, but it shapes how your treatment is set up and how closely your wellbeing is monitored. A prescriber reads your full clinical picture (your answers, your history, your current medicines) before making a decision. No software does that assessment for you.

For context on how clinical eligibility for tirzepatide works more broadly, the tirzepatide overview on this site covers the full licensing criteria.

If you or someone you know is struggling right now

This section exists because some people searching this keyword are not researching a medicine, they're in distress themselves, or worried about someone close to them. If that's you, please stop reading clinical information for a moment.

Suicidal thoughts are a medical emergency the same way chest pain is. Call 999 if there is immediate risk. The Samaritans are available any time on 116 123, free, no registration. Your GP can arrange a same-day crisis appointment. If you're already on Mounjaro and these thoughts are new or have worsened since starting treatment, tell your prescriber today, not at your next routine check-in. Contact our support team if you're a nume patient and need to reach someone quickly; we're available seven days a week.

The charity Mind has clear, practical guidance on what to do when suicidal thoughts arrive and how to help a person you're concerned about. It is worth bookmarking even if you don't need it this minute.

Mounjaro's clinical benefits for weight management are real, the evidence from SURMOUNT-1 and the NICE appraisal at TA1026 sets them out in full. But a medicine's benefits are only relevant when treatment is happening safely. Mental health is part of that safety picture, not a footnote to it.

Starting or continuing Mounjaro when you have mental health concerns

People with a history of mental health difficulties successfully use Mounjaro. Mental health conditions are not a blanket contraindication. The question a prescriber works through is whether the clinical picture as a whole (your current stability, your other medicines, your support system) makes treatment appropriate now and how it should be monitored.

Some antidepressants and mood-stabilising medicines interact with other drugs or affect body weight themselves; your prescriber needs that information to prescribe safely. If you're already taking medication for mental health, bring the full list to your consultation, and if you're considering the NHS route it's worth reading about accessing Mounjaro through your GP before your appointment. If you want to understand the broader picture of what Mounjaro is and how it works, that page is a good starting point before or after you speak to a clinician.

For anyone weighing up the private route to treatment, our Mounjaro price comparison page explains what legitimate private prescribing costs and what to look for in a provider. The clinical safety of your supply chain matters as much as the clinical review itself, counterfeit pens have been seized in the UK, some containing entirely the wrong substance. Separately, if you've been experiencing a coughing side effect while on Mounjaro, that page explains what's known and when to raise it with your prescriber.

If you'd like a prescriber to review your situation properly, including any mental health history, a free consultation with our clinical team is the right first step. There's no obligation, and it gives you a qualified answer, not a search-engine one.